ABBOTT GmbH & Co. KG
- Pharmaceutical Sales 2011
-
worldwide: 22.435 billion US $
in Germany: n/a
- Product Range
- Drug products for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis and Crohn’s disease (human monoclonal tumor necrosis factor antibody), viral infections (HIV) and bacterial infections as well as for the prophylaxis of RSV infections, cardiovascular disease, arterial hypertension, chronic kidney disease (sHTP), and also volatile anesthetics
- Key Research Areas
- Antiviral medications, drug products for the treatment of immunologic diseases, medications for neurological conditions and hematologic-oncologic diseases, medications for the treatment of diabetic renal insufficiency
- R&D Expenditure 2011
-
worldwide: 4.129 billion US $
in Germany: n/a
- Employees in the Pharmaceuticals Division 2011
-
worldwide: about 91,000 (all divisions incl. Pharma)
in Germany: more than 4,700 (all divisions incl. Pharma)
(All data based on corporate information, as of: 03/2012)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page